Cancer chemoprevention by nuts: Evidence and promises

Frontiers in Bioscience - Scholar

Volumn 4 S, Issue 1, 2012, Pages 109-120

  Falasca, Marco ^a   Casari, Ilaria ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Bioactive compounds; Cancer; Chemoprevention; Phytochemicals; Review

Indexed keywords

(6) GINGEROL; ANACARDIC ACID; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BETA CAROTENE; BUTEIN; CAFFEIC ACID; CURCUMIN; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; FOLIC ACID; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL; INOSITOL PENTAKISPHOSPHATE; MONOUNSATURATED FATTY ACID; N (2 FLUORENYL)ACETAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTIC ACID; PHYTOESTROGEN; PHYTOSTEROL; QUERCETIN; RESVERATROL; SELENIUM; SQUALENE; TAMOXIFEN; TOCOPHEROL;

ABDOMINAL OBESITY; ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BLOOD VESSEL REACTIVITY; BODY MASS; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CELL CYCLE PROGRESSION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMOPROPHYLAXIS; CHRONIC DISEASE; COLON CANCER; DNA DAMAGE; DYSLIPIDEMIA; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIFESPAN; LIVER CARCINOGENESIS; LUNG CANCER; MEDITERRANEAN DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NON MELANOMA SKIN CANCER; NONHUMAN; NUT; OXIDATIVE STRESS; PANCREAS CANCER; PRIMARY PREVENTION; PRIMARY TUMOR; PROSTATE CANCER; REHABILITATION; RISK FACTOR; SECONDARY PREVENTION; TUMOR GROWTH; URINARY TRACT INFECTION; WEIGHT GAIN; WORLD HEALTH ORGANIZATION; ANIMAL; DIET THERAPY; EPIDEMIOLOGY; FRUIT; NEOPLASM; REVIEW; VEGETABLE;

ANIMALS; EPIDEMIOLOGIC STUDIES; FRUIT; HUMANS; NEOPLASMS; NUTS; VEGETABLES;

EID: 84869383171     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s254     Document Type: Article

References (112)

1. L Cordain. SB Eaton, J. Miller, N Mann, K Hill: The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic. Eur J Clin Nutr 56, 42-52 (2002)
2. J Sabaté: Nut consumption and body weight. Am J Clin Nutr 78, 647S-650S (2003) (Pubitemid 40012560)
3. M Karlsson. S Mårild, J Brandberg. L Lönn, P Friberg, B Strandvik: Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents. Obesity (Silver Spring) 14, 1931-1939 (2006) (Pubitemid 46121923)
4. C Klein-Platat. J Drai, M Oujaa. JL Schlienger, C Simon: Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82, 1178-1184 (2005) (Pubitemid 43779715)
5. US Food and Drugs Administration. Qualified Health Claims: Letter of Enforcement Discretion - Nuts and Coronary Heart Disease. 2003. Available at: http://www.fda.gov/Food/LabelingNutrition/LabelClaims/QualifiedHealthClaims/ ucm072926.htm
6. J Sabaté. K Oda, E Ros: Nut consumption and blood lipid levels: a pooled analysis of 25 intervention trials. Arch Intern Med 10, 170, 821-827 (2010)
7. L. Maguire, S. O'Sullivan, K Galvin. TP O'Connor, NM O'Brien: Fatty acid profile, tocopherol, squalene and phytosterol content of walnuts, almonds, peanuts, hazelnuts and the macadamia nut. Int J Food Sci Nutr 55, 171-178 (2004) (Pubitemid 38996828)
8. P Casas-Agustench. M Bulló, E Ros. J Basora, J Salas-Salvadó; on behalf of the Nureta-PREDIMED investigators: Cross-sectional association of nut intake with adiposity in a Mediterranean population. Nutr Metab Cardiovasc Dis 8, [Epub ahead of print] (2010)
9. M Bes-Rastrollo. J Sabaté, E Gómez-Gracia. A Alonso, J. Martínez, MA Martínez-González: Nut consumption and weight gain in a Mediterranean cohort: The SUN study. Obesity (Silver Spring) 15, 107-116 (2007) (Pubitemid 46219790)
10. MP St-Onge: Dietary fats, teas, dairy, and nuts: potential functional foods for weight control? Am J Clin Nutr 81, 7-15 (2005)
11. J Salas-Salvadó. J Fernández-Ballart, E Ros. MA Martínez-González, M Fitó. R Estruch, D Corella. M. Fiol, E Gómez-Gracia. F Arós, G Flores. J Lapetra, R Lamuela. Raventós, V Ruiz-Gutiérrez. M Bulló, J Basora, MI Covas; PREDIMED Study Investigators: Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 168, 2449-2458 (2008)
12. P López-Uriarte. M Bulló, P Casas-Agustench. N Babio, J Salas-Salvadó: Nuts and oxidation: a systematic review. Nutr Rev 67, 497-508 (2009)
13. P Casas-Agustench. M Bulló, J Salas-Salvadó: Nuts, inflammation and insulin resistance. Asia Pac J Clin Nutr 19, 124-130 (2010)
14. R Jiang. JE Manson, M. Stampfer, S Liu. WC Willett, FB Hu: Nut and peanut butter consumption and risk of type 2 diabetes in women. Jama 288, 2554-2560 (2002) (Pubitemid 35386890)
15. R Villegas. G Yang, Y. Gao, H Cai. H Li, W Zheng, XO Shu: Dietary patterns are associated with lower incidence of type 2 diabetes in middle-aged women: the Shanghai Women's Health Study. Int J Epidemiol 39, 889-899 (2010)
16. S D. Flora, LR Ferguson: Overview of mechanisms of cancer chemopreventive agents. Mutat Res 591, 8-15 (2005) (Pubitemid 41654835)
17. YJ Surh: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768-780 (2003)
18. M Cimons: Cancer rates decline as cancer funding increases. Nat Med 4, 544 (1988)
19. F Levi. F Lucchini, E Negri, C La Vecchia: Continuing declines in cancer mortality in the European Union. Ann Oncol 18, 593-595 (2007). (Pubitemid 46359644)
20. R Doll, R Peto: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66, 1191-1308 (1981) (Pubitemid 11063920)
21. H Tsuda. Y Ohshima, H Nomoto. K Fujita, E Matsuda. M Iigo, N Takasuka, MA Moore: Cancer prevention by natural compounds. Drug Metab Pharmacokinet 19, 245-263 (2009)
22. P Gullett. AR Ruhul Amin, S Bayraktar. JM Pezzuto, D. Shin, F. Khuri, B. Aggarwal, Y. Surh, O Kucuk: Cancer prevention with natural compounds. Semin Oncol 37, 258-281 (2010)
23. M. Williams, NG Hord: The role of dietary factors in cancer prevention: beyond fruits and vegetables. Nutr Clin Prat 20, 451-459 (2005) (Pubitemid 47050814)
24. J. Satia, M. Campbell, J. Galanko, A James. C Carr, RS Sandler: Longitudinal changes in lifestyle behaviors and health status in colon cancer survivors. Cancer Epidemiol Biomarkers Prev 13, 1022-1031 (2004) (Pubitemid 38756713)
25. S. Stan, S. Singh, RE Brand: Chemoprevention strategies for pancreatic cancer. Nat Rev Gastroenterol Hepatol 7, 347-356 (2010)
26. LW Wattenberg: Chemoprevention of cancer. Cancer Res 45, 1-8 (1985) (Pubitemid 15196921)
27. YJ Surh: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768-780 (2003)
28. RH Liu: Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134, 3479S-3485S (2004) (Pubitemid 39587593)
29. J Sun. YF Chu, X Wu, RH Liu: Antioxidant and antiproliferative activities of common fruits. J Agric Food Chem 50, 7449-7454 (2002) (Pubitemid 35424917)
30. Y. Chu, J Sun. X Wu, RH Liu: Antioxidant and antiproliferative activities of vegetables. J Agric Food Chem 50, 6910-6916 (2002)
31. MA Lila: From beans to berries and beyond: teamwork between plant chemicals for protection of optimal human health. Ann N Y Acad Sci 1114, 372-380 (2007) (Pubitemid 350070413)
32. J. Li, JC Vederas: Drug discovery and natural products: end of an era or an endless frontier? Science 325, 161-165 (2009)
33. S. Gupta, J. Kim, S Prasad, BB Aggarwal: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29, 405-434 (2010)
34. G. Ommen, G. Goodman, M. Thomquist, J Barnes, MR Cullen: Effects of a combination of betacarotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334, 1150-1155 (1996) (Pubitemid 26137973)
35. E Giovannucci: Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 30, 694-704 (2003) (Pubitemid 38058173)
36. H Nishino. Y Satomi, H Tokuda, M Masuda: Cancer control by phytochemicals. Curr Pharm Des 13, 3394-3399 (2007) (Pubitemid 350201673)
37. M. Eberhardt, C. Lee, RH Liu: Antioxidant activity of fresh apples. Nature 405, 903-904 (2000) (Pubitemid 30435037)
38. C. Hennekens, J. Buring, J. Manson, M Stampfer. B Rosner, N. Cook, C Belanger. F La Motte, J. Gaziano, P. Ridker, W Willett, R Peto: Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145-1149 (1996) (Pubitemid 26137972)
39. S Knasmüller. H Steinkellner, B. Majer, E. Nobis, G Scharf, F Kassie: Search for dietary antimutagens and anticarcinogens: methodological aspects and extrapolation problems. Food Chem Toxicol 40, 1051-1062 (2002) (Pubitemid 34632636)
40. C. Cottart, V Nivet-Antoine. C Laguillier-Morizot, JL Beaudeux: Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res 54, 7-16 (2010)
41. E Ros. LC Tapsell, J Sabaté: Nuts and Berries for Heart Health. Curr Atheroscler Rep 12, 397-406 (2010)
42. R Blomhoff. MH Carlsen, L. Andersen, DR Jacobs Jr: Health benefits of nuts: potential role of antioxidants. Br J Nutr 96, 52-60 (2006)
43. P. Kris-Etherton, K. Hecker, A Bonanome. SM Coval, A. Binkoski, K. Hilpert, A. Griel, TD Etherton: Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113, 71S-88S (2002) (Pubitemid 36151834)
44. M Kornsteiner. KH Wagner, I Elmadfa: Tocopherols and total phenolics in 10 different nut types. Food Chem 53, 9436-9445 (2005)
45. B Nashed. B Yeganeh, K. HayGlass, MH Moghadasian: Antiatherogenic effects of dietary plant sterols are associated with inhibition of proinflammatory cytokine production in Apo E-KO mice. J Nutr 135, 2438-2444 (2005) (Pubitemid 41429604)
46. V Piironen. DG Lindsay, T. Miettinen, J Toivo, AM Lampi: Plant sterols: Biosynthesis, biological function and their importance to human nutrition. J Sci Food Agric 80, 939-966 (2000) (Pubitemid 30319392)
47. J. Baur, K. Pearson, N. Price, H. Jamieson, C Lerin. A Kalra, W Prabhu. JS Allard, G Lopez-Lluch. K Lewis, P. Pistell, S Poosala. KG Becker, O Boss. D Gwinn, M Wang. S Ramaswamy, K. Fishbein, R. Spencer, E. Lakatta, D L. Couteur, R. Shaw, P Navas. P Puigserver, D. Ingram, R d. Cabo, DA Sinclair: Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342 (2006) (Pubitemid 44764104)
48. R Vidavalur. H Otani, P. Singal, N Maulik: Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol 11, 217-225 (2006) (Pubitemid 44540866)
49. USDA Database for the Flavonoid Content of Selected Food. http://www.ars.usda.gov/Services/docs.htm?docid=6231.
50. L Gu. MA Kelm, J. Hammerstone, G Beecher. J Holden, D Haytowitz. S Gebhardt, RL Prior: Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr 134, 613-617 (2004) (Pubitemid 38298505)
51. M Gu. S Roy, K Raina. C Agarwal, R Agarwal: Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target. Cancer Res 69, 9465-9472 (2009)
52. C Frontela. C Martínez, D Perez, G Ros: Phytic acid and inositol phosphates in infant cereal flours: The effect of processing. Abstract 99E-10, IFT Annual Meeting, Las Vegas, NV July 12-16 (2004)
53. Q Chen: Determination of phytic acid and inositol pentakisphosphates in foods by high-performance ion chromatography. Journal of Agricultural and Food Chemistry 52, 4604-4613 (2004)
54. RA Weinberg: Mechanisms of malignant progression. Carcinogenesis 29, 1092-1095 (2008) (Pubitemid 351958686)
55. A. Chiang, J Massagué: Molecular basis of metastasis. N Engl J Med 359, 2814-2823 (2008)
56. M Falasca: PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anticancer drugs. Curr Pharm Des 16, 1410-1416 (2010)
57. M Karin: How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogen, 22, 6867-6874 (1999)
58. S Reuter. SC Gupta, M. Chaturvedi, BB Aggarwal: Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med 49, 1603-1616 (2010)
59. World Cancer Research Fund & American Investigation of Cancer Reaserch: Food, nutrition and the prevention of cancer: a global perspective. Menasha USA: Banta Book Group (1997)
60. C. Chen, JB Blumberg: Phytochemical composition of nuts. Asia Pac J Clin Nutr 1, 329-332 (2008)
61. BN Ames: Understanding the causes of aging and cancer. Microbiologia 11, 305-308 (1995)
62. P Pisani. DM Parkin, N Muñoz, J Ferlay: Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 6, 387-400 (1997) (Pubitemid 27270542)
63. B. Moore, D. Arenberg, C. Addison, M. Keane, P. Polverini, RM Strieter: CXC chemokines mechanism of action in regulating tumor angiogenesis. Angiogenesis 2, 123-134 (1998) (Pubitemid 128511980)
64. C. Yang, J. Landau, M. Huang, HL Newmark: Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nur, 21, 381-406 (2001) (Pubitemid 32695277)
65. B. Henderson, R. Ross, MC Pike: Hormonal chemoprevention of cancer in women. Science 259, 633-638 (1993) (Pubitemid 23066285)
66. P. Gann, C. Hennekens, J Ma. C Longcope, MJ Stampfer: Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88, 1118-1126 (1996) (Pubitemid 26274606)
67. P Greenwald. CK Clifford, JA Milner: Diet and cancer prevention. Eur J Cancer 37, 948-965 (2001) (Pubitemid 32401123)
68. M Messina. W McCaskill-Stevens, JW Lampe: Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 98, 1275-1284 (2006) (Pubitemid 44530723)
69. G Razzini. CP Berrie, S Vignati. M Broggini, G Mascetta. A Brancaccio, M Falasca: Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. Faseb J 14, 1179-1187 (2000) (Pubitemid 30350400)
70. E Piccolo. S Vignati, T Maffucci. PF Innominato, A. Riley, BV. Potter, P. Pandolfi, M Broggini. S Iacobelli, P Innocenti, M Falasca: Inositol Pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway. Oncogene 23, 1754-1765 (2004) (Pubitemid 38445167)
71. T Maffucci. E Piccolo, A Cumashi. M Iezzi, A. Riley, A Saiardi. HY Godage, C Rossi. M Broggini, S Iacobelli. BVL Potter, P Innocenti, M Falasca: Inhibition of the PI 3-K/Akt pathway by Inositol pentakisphosphate results in antangiogenic and anti-tumour effects. Cancer Res 65, 8339-8349 (2005) (Pubitemid 41330599)
72. E Bråkenhielm. R Cao, Y Cao: Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. Faseb J 15, 1798-1800 (2001)
73. P Fresco. F Borges, M. Marques, C Diniz: The anticancer properties of dietary polyphenols and its relation with apoptosis. Curr Pharm Des 16, 114-134 (2010)
74. B Sung. MK Pandey, K. Ahn, T Yi. MM Chaturvedi, M Liu, BB Aggarwal: Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 111, 4880-4891 (2008)
75. S. Gupta, J. Kim, S Prasad, BB Aggarwal: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29, 405-434 (2010)
76. AF Chambers: Influence of diet on metastasis and tumor dormancy. Clin Exp Metastasis 26, 61-66 (2008)
77. K Maiese. ZZ Chong, J Hou, YC Shang: Oxidative stress: Biomarkers and novel therapeutic pathways. Exp Gerontol 45, 217-234 (2010)
78. J Alexander. R Reistad, S Hegstad. H Frandsen, K Ingebrigtsen. JE Paulsen, G Becher: Biomarkers of exposure to heterocyclic amines: approaches to improve the exposure assessment. Food Chem Toxicol 40, 1131-1137 (2002) (Pubitemid 34626878)
79. K. Adom, RH Liu: Antioxidant activity of grains. J Agric Food Chem 50, 6182-61877 (2002)
80. C. González, J Salas-Salvadó: The potential of nuts in the prevention of cancer. Br J Nutr 96, 87-94 (2006)
81. M Jenab. P Ferrari, N Slimani. T Norat, C Casagrande. K Overad, A Olsen. C Stripp, A Tjønneland. MC Boutron-Ruault, F Clavel-Chapelon. E Kesse, A Nieters. M Bergmann, H Boeing. A Naska, A Trichopoulou. D Palli, V Krogh. E Celentano, R Tumino. C Sacerdote, H. Buenode-Mesquita, M. Ocké, P. Peeters, D Engeset. JR Quirós, C. González, C Martínez. MD Chirlaque, E Ardanaz. M Dorronsoro, P Wallström. R Palmqvist, B Va. Guelpen, S Bingham. MA San Joaquin, R Saracci. R Kaaks, E Riboli: Association of nut and seed intake with colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 13, 15951-603 (2004)
82. C. Yeh, S. You, C. Chen, FC Sung: Peanut consumption and reduced risk of colorectal cancer in women: a prospective study in Taiwan. World J Gastroenterol 12, 222-227 (2006) (Pubitemid 43336919)
83. E Petridou. S Kedikoglou, P Koukoulomatis. N Dessypris, D Trichopoulos: Diet in relation to endometrial cancer risk: a case-control study in Greece. Nutr Cancer 44, 16-22 (2002) (Pubitemid 36359316)
84. J. Hebert, T. Hurley, B. Olendzki, J Teas. Y Ma, JS Hampl: Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst 90, 1637-1647 (1998) (Pubitemid 28523438)
85. P. Mills, W. Beeson, R. Phillips, GE Fraser: Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer 64, 598-604 (1989) (Pubitemid 19185206)
86. M. Jain, G. Hislop, G. Howe, P Ghadirian: Plant foods, antioxidants, and prostate cancer risk: findings from casecontrol studies in Canada. Nutr Cancer 34, 173-184 (1999) (Pubitemid 29511115)
87. Y Hoshiyama, T Sasaba: A case-control study of stomach cancer and its relation to diet, cigarettes, and alcohol consumption in Saitama Prefecture, Japan. Cancer Causes Control 3, 441-448 (1992)
88. D Trichopoulos. G Ouranos, N. Day, A Tzonou. O Manousos, C Papadimitriou, A Trichopoulos: Diet and cancer of the stomach: a case-control study in Greece. Int J Cancer 36, 291-297 (1985) (Pubitemid 16250990)
89. S. Mayne, G. Handelman, G Beecher: Beta-Carotene and lung cancer promotion in heavy smokers-a plausible relationship? J Natl Cancer 151, 3151-3155 (1996)
90. L Lever, R Marks: Topical retinoid treatment for skin cancer: a review. Skin Pharmacol 4, 125-131 (1991)
91. W. Hardman, G Ion: Suppression of implanted MDAMB 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer 60, 666-674 (2008)
92. C. Mann, C. Neal, G Garcea. MM Manson, A. Dennison, DP Berry: Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis. Eur J Cancer Prev 18, 13-25 (2009)
93. J. Baur, DA Sinclair: Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493-506 (2006) (Pubitemid 44136961)
94. S Shankar. G Singh, RK Srivastava: Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 12, 4839-4854 (2007)
95. B Juhasz. B Varga, R Gesztelyi. A Kemeny-Beke, J Zsuga, A Tosaki: Resveratrol: A Multifunctional Cytoprotective Molecule. Curr Pharm Biotechnol 2010 Sep. 28 (Epub ahead of print)
96. A Bishayee. T Politis, AS Darvesh: Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma. Cancer Treat Rev 36, 43-53 (2009)
97. T. Chung, S. Moon, Y. Chang, J. Ko, Y. Lee, G Cho. SH Kim, J. Kim, CH Kim: Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. Faseb J 18, 1670-1681 (2004) (Pubitemid 39463706)
98. U. Jin, T. Chung, S. Kang, S. Suh, J. Kim, K. Chung, Y. Gu, I Suzuki, CH Kim: Caffeic acid phenyl ester in propolis is a strong inhibitor of matrix metalloproteinase-9 and invasion inhibitor: isolation and identification. Clin Chim Acta 362, 57-64 (2005) (Pubitemid 41597089)
99. T Tanaka. H Iwata, K Niwa. Y Mori, H Mori: Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats. Jpn J Cancer Res 79, 1297-1303 (1988) (Pubitemid 20019407)
100. C Bell, S Hawthorne: Ellagic acid, pomegranate and prostate cancer - a mini review. J Pharm Pharmacol 60, 139-144 (2008) (Pubitemid 351211828)
101. Z. Yuan, L. Chen, Y. Wei, L. Fan, M. Tang, GL Yang: Nanoliposomal quercetin inhibits formation of malignant ascites of hepatocellular carcinoma. Ai Zheng 25, 941-945 (2006)
102. P. Kris-Etherton, K. Hecker, A Bonanome. SM Coval, A. Binkoski, K. Hilpert, H Griel Hung: Dietary quercetin inhibits proliferation of lung carcinoma cells. Forum Nutr 60, 146-157 (2007)
103. S. Duthie, A. Collins, G. Duthie, VL Dobson: Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes. Mutat Res 24, 223-231 (1997) (Pubitemid 27481049)
104. S Ramos. M Alía, L Bravo, L Goya: Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem 53, 1271-1280 (2005) (Pubitemid 40270427)
105. TJ Smith: Squalene: potential chemopreventive agent. Expert Opin Investig Drugs 9, 1841-1848 (2000) (Pubitemid 30639333)
106. I Vucenik, AM Shamsuddin: Protection against cancer by dietary IP6 and inositol. Nutr Cancer 55, 109-125 (2006) (Pubitemid 44719624)
107. I Vucenik, AM Shamsuddin: Cancer inhibition by inositol hexaphosphate (IP6) and inositol: from laboratory to clinic. Journal of Nutrition 133, 3778S-3784S (2003) (Pubitemid 37392600)
108. M Falasca: Anti-cancer activity of the bioactive compound inositol pentakisphosphates. Phytochem Rev 8, 369-374 (2009)
109. M Falasca. D Chiozzotto, H. Godage, M Mazzoletti. AM Riley, S Previdi. BVL Potter, M Broggini, T Maffucci: A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1, 3, 4, 5, 6-pentakisphosphate. Br J Cancer 102, 104-114 (2010)
110. L Zhang. W Chen, X Li: A novel anticancer effect of butein: inhibition of invasion through the ERK1/2 and NFkappa B signaling pathways in bladder cancer cells. Febs Lett 582, 1821-8 (2008)
111. B Sung. MK Pandey, K. Ahn, T Yi. MM Chaturvedi, M Liu, BB Aggarwal: Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-kappaB-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-kappaBalpha kinase, leading to potentiation of apoptosis. Blood 111, 4880-4891 (2008)
112. D. Schultz, N. Wickramasinghe, M. Ivanova, S. Isaacs, S. Dougherty, Y Imbert-Fernandez. AR Cunningham, C Chen, CM Klinge: Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation. Mol Cancer Ther 9, 594-605 (2010)